DK0673913T3 - Calcium-alkali metal citrate compounds as well as their use as drugs - Google Patents

Calcium-alkali metal citrate compounds as well as their use as drugs

Info

Publication number
DK0673913T3
DK0673913T3 DK95104030T DK95104030T DK0673913T3 DK 0673913 T3 DK0673913 T3 DK 0673913T3 DK 95104030 T DK95104030 T DK 95104030T DK 95104030 T DK95104030 T DK 95104030T DK 0673913 T3 DK0673913 T3 DK 0673913T3
Authority
DK
Denmark
Prior art keywords
alkali metal
calcium
drugs
well
metal citrate
Prior art date
Application number
DK95104030T
Other languages
Danish (da)
Inventor
Alfons Dr Rer Nat Carcasona
Klaus Prof Dr Rer Reinhardt
Paul-Otto Prof Dr Rer Schwille
Wilfried Dr Rer Nat Wochter
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19944409948 external-priority patent/DE4409948A1/en
Priority claimed from DE19944409949 external-priority patent/DE4409949C2/en
Application filed by Madaus Ag filed Critical Madaus Ag
Application granted granted Critical
Publication of DK0673913T3 publication Critical patent/DK0673913T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Calcium alkali metal citrates of formula CaXC6H5O7 (I), where X = alkali metal, and their hydrates are new. Also claimed are pharmaceutical compsns. contg. (I).
DK95104030T 1994-03-23 1995-03-18 Calcium-alkali metal citrate compounds as well as their use as drugs DK0673913T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944409948 DE4409948A1 (en) 1994-03-23 1994-03-23 New calcium alkali metal citrate salts
DE19944409949 DE4409949C2 (en) 1994-03-23 1994-03-23 Use of calcium alkali citrates for the prophylaxis and treatment of degenerative diseases of the bone structure

Publications (1)

Publication Number Publication Date
DK0673913T3 true DK0673913T3 (en) 1999-09-20

Family

ID=25934979

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95104030T DK0673913T3 (en) 1994-03-23 1995-03-18 Calcium-alkali metal citrate compounds as well as their use as drugs

Country Status (6)

Country Link
EP (1) EP0673913B1 (en)
JP (2) JP2948122B2 (en)
AT (1) ATE176662T1 (en)
DE (1) DE59505063D1 (en)
DK (1) DK0673913T3 (en)
ES (1) ES2129146T3 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287607B2 (en) * 1999-07-19 2001-09-11 Mission Pharmacal Company Potassium calcium citrate compositions and methods therefor
DE102005040423A1 (en) 2005-08-25 2007-03-01 Lahrsow, Jobst, Dr. med. dent. Food supplement for the supply of minerals
US8859824B2 (en) 2009-01-22 2014-10-14 Mission Pharmacal Company Dual cation dual anion coordination complexes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2727304C2 (en) * 1977-06-16 1982-12-02 Dr. Madaus & Co, 5000 Köln Acid alkali citrate, its manufacture and use

Also Published As

Publication number Publication date
EP0673913B1 (en) 1999-02-10
JP2948122B2 (en) 1999-09-13
EP0673913A1 (en) 1995-09-27
JPH0840975A (en) 1996-02-13
DE59505063D1 (en) 1999-03-25
ES2129146T3 (en) 1999-06-01
JPH11255642A (en) 1999-09-21
ATE176662T1 (en) 1999-02-15

Similar Documents

Publication Publication Date Title
FI950309A (en) Proliiniamidijohdannaisia
AU1642795A (en) Substituted pyridylpyrazoles
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
GB9801690D0 (en) Therapeutic agents
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
FI920023A0 (en) HETEROARYLPIPERAZINFOERENINGAR SOM ANTIPSYKOTISKA AEMNEN.
NO952207D0 (en) Use of 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexole) as an antidepressant
BR9714650A (en) "pharmaceutical derivatives of aminophosphonic acid"
DK0673913T3 (en) Calcium-alkali metal citrate compounds as well as their use as drugs
PT855398E (en) SASQUITERPENE DERIVATIVES HAVING ANTIVIRAL ACTIVITY
DK284588A (en) BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS.
ES2129053T3 (en) NEW DERIVATIVES OF PHOSFOLIPIDS.
DE3872425D1 (en) SUBSTITUTED TETRAHYDROISOCHINOLINE COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL AGENTS CONTAINING THEM.
DK0677513T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its preparation and use
DK0587048T3 (en) Heteroarenylpiperazines, a process for their preparation and their use as drugs
SE9803280D0 (en) Novel compounds
FI904033A0 (en) NYA 1,3-OXAZINER.
PT856511E (en) INDICATACINE PENTA-HYDRATED CALCIUM AND ITS PREPARATION
ES2019857T3 (en) PROCEDURE FOR THE MANUFACTURE OF AMINOPROPANOLDERIVATES OF COMPOUNDS OF 3- (2'-HYDROXIPHENYL) -1-PROPANONE.
ES2150392B1 (en) "PARENTERAL COMPOSITIONS BASED ON CALCITONIN".
SU1455632A1 (en) O, O-DIETHYL-N- (1-PROPYLTIO-2-HYDROXY-2-METHYL-PROPYLIDENE) AMIDOTHIOPHOSPHATE OWNED BACTERICIDAL